Pharmaceutical Facility – Decommissioning
GlaxoSmithKline Penicillin Facility, Heppignies, Belgium
Key Project Elements • Site Closure and Handover • Decontamination Sampling
and Data Management
• Risk Classification • Asset and Equipment
Transfers and Disposal
• Hazardous Waste
• Oversight of
Decommissioning and Demolition
• Review and Oversight of
Contaminated Land Management
CRA provided a wide range of consultancy services associated with the closure and decommissioning of a former GSK penicillin factory located in Heppignies, Belgium. This included an assessment of site operational procedures and migration of the site from operations to safe shutdown and decontamination in preparation for sale of the facility. The facility closure and decommissioning activities included design of a site-‐specific sampling program for collection of samples from the building fabric and structure, and an assessment of human health risks associated with penicillin, volatile organic compounds and fuel oil within the buildings. CRA developed site-‐specific decontamination and cleaning protocols to facilitate divestment and disposal of site assets. CRA provided direct management and oversight of: • Site closure and engineering handover; • Asset and equipment transfers, sale and disposal; • Removal of site hazardous materials and storage tank cleaning; • Service isolations and security upgrades; • Preparation of decontamination and internal demolition methods; • Contracting, oversight and management of internal decontamination, decommissioning and demolition of all high risk areas. In addition, CRA provided review of all previous contaminated land assessments, oversight of intrusive investigations, and installation of a remediation pilot plant (soil vapour extraction).
Published on Dec 12, 2011
• Review and Oversight of Contaminated Land Management GlaxoSmithKline Penicillin Facility...